The Diagnostic Workup: EMG and Antibody Testing

The process of diagnosing Isaacs syndrome relies on a combination of electrical “stress tests” for your nerves and specialized blood work, while excluding mimics. Because this condition is so rare, your medical team must look for specific characteristic patterns that distinguish it from more common neurological issues.

The Key Test: EMG and Nerve Studies

To help evaluate whether your nerves are hyperexcitable, doctors use Electromyography (EMG) and Nerve Conduction Studies (NCS). These tests record the electrical activity of your muscles and the speed at which your nerves carry signals. (During an EMG, a needle is inserted into the muscle, which can cause brief discomfort). In Isaacs syndrome, the report will often feature several key terms that describe the signals:

• Neuromyotonic Discharges: These are high-frequency bursts of electrical activity that sound like a “dive bomber” on the EMG audio monitor ^[1][2].
• After-Discharges: When a doctor stimulates a nerve during the test, your nerve continues to fire extra signals even after the stimulation has stopped ^[2][3].
• Myokymic Discharges: Often appearing as “multiplets” (doublets, triplets, or groups of signals), these represent the “rippling” movement you see under your skin ^[4][5].
• Fasciculations: These are individual spontaneous twitches that occur alongside the more complex discharges ^[4].

In a specific Japanese survey, 90% of patients with Isaacs syndrome showed these types of electrical hyperexcitability on their tests ^[3]. However, a nondiagnostic study does not automatically rule out Isaacs syndrome, as findings vary with disease activity and medications.

Antibody Testing: Navigating the Names

For many years, doctors used a broad test called the “VGKC-complex” antibody test. However, modern medical guidelines have changed. Research now shows that a generic “positive” VGKC test is not specific enough to confirm an autoimmune disease ^[6][7].

Instead, your doctor should use a cell-based assay (CBA) to look for two specific antibodies:

1. CASPR2: This is the antibody most closely linked to the muscle stiffness and rippling of Isaacs syndrome ^[8][9].
2. LGI1: While sometimes present in Isaacs, this is more commonly associated with brain-related symptoms like memory loss or confusion ^[10][11].

The “Antibody-Negative” Reality

It is very common—and often confusing—to receive a “negative” result on these antibody tests even if you have Isaacs syndrome. In a nationwide Japanese survey, only about 22% of patients tested positive for CASPR2 or LGI1 antibodies ^[3]. This means roughly 78% of patients in that cohort were antibody-negative ^[3]. A negative result does not mean the disease isn’t real; it simply means that science may not have identified your specific antibody yet, or your condition is being driven by a different part of the immune system ^[12][13].

What the tests can and cannot show: EMG supports the diagnosis, antibody testing may be negative, and neither a single antibody result nor a single EMG phrase should be interpreted in isolation.

Essential Safety: Malignancy Screening

Because Isaacs syndrome is sometimes associated with an overactive immune system reacting to a tumor, it can sometimes be a “warning sign” that the body is reacting to an underlying growth elsewhere. This is known as a paraneoplastic presentation ^[14].

Initial screening for associated malignancies is appropriate. This often includes screening for:

• Thymoma: A tumor of the thymus gland (located in the chest). This is a common growth associated with Isaacs syndrome ^[15][16].
• Lymphoma: A type of blood cancer that has also been linked to the condition ^[15]. (Small-cell lung cancer and other tumors have also been reported).

Most doctors will order initial imaging, which may be a CT scan of the chest with contrast to look for a thymoma ^[17][18]. (Keep in mind contrast, radiation, allergy, and pregnancy considerations). Screening is individualized with oncology/neurology guidance, and symptom severity alone is not an indication for full-body PET scans ^[18]. Finding and treating these underlying issues—if they are present—is often a critical step in managing the neurological symptoms themselves ^[19].